Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Pulmonary Hypertension, September 2017

Free Subscription


Abstracts

Retrieve all available abstracts of the following 107 articles:
HTML format


 

Single Articles

  1. CHICOTKA S, Burkhoff D, Dickstein ML, Bacchetta M, et al
    Extracorporeal Membrane Oxygenation for End-Stage Interstitial Lung Disease With Secondary Pulmonary Hypertension at Rest and Exercise: Insights From Simulation Modeling.
    ASAIO J. 2017 Aug 31. doi: 10.1097/MAT.0000000000000646.
    Abstract    

    Abstract available

  2. BRYANT AJ, Shenoy V, Fu C, Marek G, et al
    Myeloid-derived Suppressor Cells are Necessary for Development of Pulmonary Hypertension.
    Am J Respir Cell Mol Biol. 2017 Sep 1. doi: 10.1165/rcmb.2017-0214.
    Abstract    

    Abstract available

  3. JIANG R, Zhao QH, Wu WH, Zhang R, et al
    Efficacy and Safety of a Calcium Sensitizer, Levosimendan, in Patients with Right Heart Failure due to Pulmonary Hypertension.
    Clin Respir J. 2017 Sep 1. doi: 10.1111/crj.12699.
    Abstract    

    Abstract available

  4. KAMENY RJ, Colglazier E, Nawaytou H, Moore P, et al
    Pushing the envelope: a treat and repair strategy for patients with advanced pulmonary hypertension associated with congenital heart disease.
    Pulm Circ. 2017 Sep 1:2045893217726086. doi: 10.1177/2045893217726086.
    Abstract    

    Abstract available

  5. HUTCHINS KK, Ross RD, Kobayashi D, Martin A, et al
    Treatment of Refractory Infantile Hemangiomas and Pulmonary Hypertension With Sirolimus in a Pediatric Patient.
    J Pediatr Hematol Oncol. 2017 Aug 30. doi: 10.1097/MPH.0000000000000961.
    Abstract    

    Abstract available

  6. SUTHERLAND-SMITH J, Hankin EJ, Cunningham SM, Sato AF, et al
    Comparison of a computed tomographic pulmonary trunk to aorta diameter ratio with echocardiographic indices of pulmonary hypertension in dogs.
    Vet Radiol Ultrasound. 2017 Aug 30. doi: 10.1111/vru.12540.
    Abstract    

    Abstract available

  7. CZECZOK T, Lin P, Yi E
    Plexogenic pulmonary hypertension associated with POEMS syndrome.
    Respir Med Case Rep. 2017;22:168-170.
    Abstract    

    Abstract available

  8. FLORENTIN J, Dutta P
    Origin and production of inflammatory perivascular macrophages in pulmonary hypertension.
    Cytokine. 2017 Aug 28. pii: S1043-4666(17)30248.
    Abstract    

    Abstract available

  9. RIBEIRO EL, Fragoso IT, Dos Santos Gomes FO, Oliveira AC, et al
    Diethylcarbamazine: A potential treatment drug for pulmonary hypertension?
    Toxicol Appl Pharmacol. 2017 Aug 26. pii: S0041-008X(17)30354.
    Abstract    

    Abstract available

  10. WU K, Zhang Q, Wu X, Lu W, et al
    Chloroquine is a Potent Pulmonary Vasodilator that Attenuates Hypoxia-induced Pulmonary Hypertension.
    Br J Pharmacol. 2017 Aug 28. doi: 10.1111/bph.13990.
    Abstract    

    Abstract available

  11. YU W, Ji W, Mi L, Lin C, et al
    Mechanisms of Nacetylcysteine in reducing monocrotalineinduced pulmonary hypertension in rats: Inhibiting the expression of Nox1 in pulmonary vascular smooth muscle cells.
    Mol Med Rep. 2017 Aug 22. doi: 10.3892/mmr.2017.7326.
    Abstract    

    Abstract available

  12. HOESEIN FAM, Voortman M, Kwakkel-van Erp JM, Luijk B, et al
    Images in COPD: Combined Pulmonary Emphysema and Fibrosis with Pulmonary Hypertension.
    Chronic Obstr Pulm Dis. 2017;4:76-80.
    Abstract    



  13. SANTOS-MARTINEZ LE, Rodriguez-Almendros NA, Flores-Garcia CA, Soto-Marquez P, et al
    [Non surgical chronic thromboembolic pulmonary hypertension in a subject with antiphospholipid syndrome].
    Arch Cardiol Mex. 2017 Aug 23. pii: S1405-9940(17)30075.
    Abstract    



  14. BOUDJEMLINE Y, Sizarov A, Malekzadeh-Milani S, Mirabile C, et al
    Safety and Feasibility of the Transcatheter Approach to Create a Reverse Potts Shunt in Children With Idiopathic Pulmonary Arterial Hypertension.
    Can J Cardiol. 2017;33:1188-1196.
    Abstract    

    Abstract available

  15. ARMSTRONG GT, Tolle JJ, Piana R, Santucci A, et al
    Exercise right heart catheterization for pulmonary hypertension identified on screening echocardiography in adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort.
    Pediatr Blood Cancer. 2017 Aug 26. doi: 10.1002/pbc.26769.
    Abstract    

    Abstract available

  16. GARCIA-RIVAS G, Jerjes-Sanchez C, Rodriguez D, Garcia-Pelaez J, et al
    A systematic review of genetic mutations in pulmonary arterial hypertension.
    BMC Med Genet. 2017;18:82.
    Abstract    

    Abstract available

  17. NIETO ESTRADA VH, Molano Franco D, Medina RD, Gonzalez Garay AG, et al
    Interventions for preventing high altitude illness: Part 1. Commonly-used classes of drugs.
    Cochrane Database Syst Rev. 2017;6:CD009761.
    Abstract    

    Abstract available

  18. VASANTHAN V, Garg M, Maruyama M, Michelakis E, et al
    Extended Bridge to Heart and Lung Transplantation Using Pumpless Extracorporeal Lung Assist.
    Can J Cardiol. 2017;33:950.
    Abstract    

    Abstract available

  19. YAMAMOTO K, Suzuki T, Imamura R, Nagano T, et al
    Synthesis of both enantiomers of 1,2,3,4-tetrahydroisoquinoline derivative IPPAM-1 and enantio-dependency of its positive allosteric modulation of prostacyclin receptor.
    Bioorg Med Chem Lett. 2017;27:2567-2570.
    Abstract    

    Abstract available

  20. ORRIOLS M, Gomez-Puerto MC, Ten Dijke P
    BMP type II receptor as a therapeutic target in pulmonary arterial hypertension.
    Cell Mol Life Sci. 2017;74:2979-2995.
    Abstract    

    Abstract available

  21. JAFFEY JA, Williams KJ, Masseau I, Krueger M, et al
    Vasoproliferative process resembling pulmonary capillary hemangiomatosis in a cat.
    BMC Vet Res. 2017;13:72.
    Abstract    

    Abstract available

  22. MAO M, Yu X, Ge X, Gu R, et al
    Acetylated cyclophilin A is a major mediator in hypoxia-induced autophagy and pulmonary vascular angiogenesis.
    J Hypertens. 2017;35:798-809.
    Abstract    

    Abstract available

  23. GHOSH RK, Ball S, Das A, Bandyopadhyay D, et al
    Selexipag in Pulmonary Arterial Hypertension: Most Updated Evidence From Recent Preclinical and Clinical Studies.
    J Clin Pharmacol. 2017;57:547-557.
    Abstract    

    Abstract available

  24. VEMULAPALLI S, Cohen L, Hsu V
    Prevalence and risk factors for left ventricular diastolic dysfunction in a scleroderma cohort.
    Scand J Rheumatol. 2017;46:281-287.
    Abstract    

    Abstract available

  25. WANG C, Huang XF, Cai QQ, Cao XX, et al
    Prognostic study for overall survival in patients with newly diagnosed POEMS syndrome.
    Leukemia. 2017;31:100-106.
    Abstract    

    Abstract available

  26. GODDARD JC, Armstrong IJ, Kiely DG, Elliot CA, et al
    Combining creative writing and narrative analysis to deliver new insights into the impact of pulmonary hypertension.
    BMJ Open Respir Res. 2017;4:e000184.
    Abstract    

    Abstract available

  27. KOTB MA, Abd El Satar I, Badr AM, Anis NH, et al
    Pulmonary hypertension and cardiac hypertrophy in children recipients of orthotopic living related liver transplantation.
    J Adv Res. 2017;8:663-668.
    Abstract    

    Abstract available

  28. GIRERD B, Weatherald J, Montani D, Humbert M, et al
    Heritable pulmonary hypertension: from bench to bedside.
    Eur Respir Rev. 2017;26.
    Abstract    

    Abstract available

  29. ZHANG XL, Duan XM, Wang FY, Zhang X, et al
    An Infant with Abernethy Malformation Associated with Heterotaxy and Pulmonary Hypertension.
    Chin Med J (Engl). 2017;130:2257-2258.
    Abstract    



  30. WIEDENROTH CB, Liebetrau C, Gall H, Risch T, et al
    The effective systematic heparin pre-treatment on thrombus formation on pulmonary artery catheter tips during pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: a randomized, double-blind study.
    J Thromb Thrombolysis. 2017 Sep 5. doi: 10.1007/s11239-017-1547.
    Abstract    

    Abstract available

  31. SZTURMOWICZ M, Kacprzak A, Kus J
    Pulmonary hypertension in diffuse parenchymal lung diseases - is there any benefit of PAH-specific therapy?
    Adv Respir Med. 2017;85:216-223.
    Abstract    

    Abstract available

  32. UENO T, Saka R, Takama Y, Yamanaka H, et al
    Onset ages of hepatopulmonary syndrome and pulmonary hypertension in patients with biliary atresia.
    Pediatr Surg Int. 2017 Sep 4. doi: 10.1007/s00383-017-4136.
    Abstract    

    Abstract available

  33. KALLIANOS K, Brooks GC, Mukai K, Seguro de Carvalho F, et al
    Cardiac Magnetic Resonance Evaluation of Left Ventricular Myocardial Strain in Pulmonary Hypertension.
    Acad Radiol. 2017 Aug 30. pii: S1076-6332(17)30333.
    Abstract    

    Abstract available

  34. JASINSKA-STROSCHEIN M, Orszulak-Michalak D
    Novel strategies for treatment of pulmonary arterial hypertension.
    Postepy Hig Med Dosw (Online). 2017;71:577-588.
    Abstract    

    Abstract available

  35. TANG X, Chen XF, Chen HZ, Liu DP, et al
    Mitochondrial Sirtuins in cardiometabolic diseases.
    Clin Sci (Lond). 2017;131:2063-2078.
    Abstract    

    Abstract available

  36. WU D, Zhang T, Chen Y, Huang Y, et al
    Discovery and Optimization of Chromeno[2,3-c]pyrrol-9(2H)-ones as Novel Selective and Orally Bioavailable Phosphodiesterase 5 Inhibitors for the Treatment of Pulmonary Arterial Hypertension.
    J Med Chem. 2017;60:6622-6637.
    Abstract    

    Abstract available

  37. WANG L, Jiang R, Zhao QH, He J, et al
    [Clinical analysis of Behcet disease associated with pulmonary vascular disease].
    Zhonghua Jie He He Hu Xi Za Zhi. 2017;40:343-348.
    Abstract    

    Abstract available

  38. BAKER WL, Darsaklis K, Singhvi A, Salerno EL, et al
    Selexipag, an Oral Prostacyclin-Receptor Agonist for Pulmonary Arterial Hypertension.
    Ann Pharmacother. 2017;51:488-495.
    Abstract    

    Abstract available

  39. BURRAGE LC, Guillerman RP, Das S, Singh S, et al
    Lung Transplantation for FLNA-Associated Progressive Lung Disease.
    J Pediatr. 2017 Apr 28. pii: S0022-3476(17)30457.
    Abstract    

    Abstract available

  40. LIAO JP, Hu Y, Qiu JX, Jin Z, et al
    [Clinical characteristics and prognosis of mediastinal fibrosis].
    Zhonghua Jie He He Hu Xi Za Zhi. 2017;40:199-204.
    Abstract    

    Abstract available

  41. MOREO K, Lattimer C, Lett JE, Heggen-Peay CL, et al
    Integrated Transitions of Care for Patients With Rare Pulmonary Diseases.
    Prof Case Manag. 2017;22:54-63.
    Abstract    

    Abstract available

  42. THOMPSON AA, Lawrie A
    Targeting Vascular Remodeling to Treat Pulmonary Arterial Hypertension.
    Trends Mol Med. 2017;23:31-45.
    Abstract    

    Abstract available

  43. SISTA AK, Miller LE, Kahn SR, Kline JA, et al
    Persistent right ventricular dysfunction, functional capacity limitation, exercise intolerance, and quality of life impairment following pulmonary embolism: Systematic review with meta-analysis.
    Vasc Med. 2017;22:37-43.
    Abstract    

    Abstract available

  44. YAZAL ERDEM A, Emir S, Demir HA, Ozyoruk D, et al
    Focal Nodulary Hyperplasia of the Liver Due to Congenital Portosystemic Shunt: A Rare Condition Mimicking Hepatocellulary Carcinoma.
    J Pediatr Hematol Oncol. 2017;39:e8-e10.
    Abstract    

    Abstract available

  45. LIU A, Hacker T, Eickhoff JC, Chesler NC, et al
    Estrogen Preserves Pulsatile Pulmonary Arterial Hemodynamics in Pulmonary Arterial Hypertension.
    Ann Biomed Eng. 2017;45:632-643.
    Abstract    

    Abstract available

  46. MIAO R, Wang Y, Wan J, Leng D, et al
    Microarray Analysis and Detection of MicroRNAs Associated with Chronic Thromboembolic Pulmonary Hypertension.
    Biomed Res Int. 2017;2017:8529796.
    Abstract    

    Abstract available

  47. FU LC, Lv Y, Zhong Y, He Q, et al
    Tyrosine phosphorylation of Kv1.5 is upregulated in intrauterine growth retardation rats with exaggerated pulmonary hypertension.
    Braz J Med Biol Res. 2017;50:e6237.
    Abstract    

    Abstract available

  48. JARRETT H, Barnett C
    HIV-associated pulmonary hypertension.
    Curr Opin HIV AIDS. 2017 Sep 11. doi: 10.1097/COH.0000000000000418.
    Abstract    

    Abstract available

  49. KABBACH G, Mukherjee D
    Pulmonary Hypertension secondary to Left Heart Disease.
    Curr Vasc Pharmacol. 2017 Sep 12. doi: 10.2174/1570161115666170913105424.
    Abstract    

    Abstract available

  50. OLIVEIRA RKF, Faria-Urbina M, Maron BA, Santos M, et al
    Functional impact of exercise pulmonary hypertension in patients with borderline resting pulmonary arterial pressure.
    Pulm Circ. 2017;7:654-665.
    Abstract    

    Abstract available

  51. THENAPPAN T
    Pulmonary hypertension in chronic kidney disease: a hemodynamic characterization.
    Pulm Circ. 2017;7:567-568.
    Abstract    



  52. INOHARA T, Vemulapalli S
    Percutaneous edge-to-edge leaflet repair: a solution to the risk-treatment paradox of mitral regurgitation complicated by pulmonary hypertension?
    Eur J Heart Fail. 2017 Sep 10. doi: 10.1002.
    Abstract    



  53. GOLDBERG AB, Mazur W, Kalra DK
    Pulmonary hypertension: diagnosis, imaging techniques, and novel therapies.
    Cardiovasc Diagn Ther. 2017;7:405-417.
    Abstract    

    Abstract available

  54. YINGZHONG Y, Yaping W, Jin X, Rili G, et al
    The susceptibility gene screening in a Chinese high-altitude pulmonary edema family by whole-exome sequencing.
    Yi Chuan. 2017;39:135-142.
    Abstract    

    Abstract available

  55. DUBROCK HM, Goldberg DS, Sussman NL, Bartolome SD, et al
    Predictors of Waitlist Mortality in Portopulmonary Hypertension.
    Transplantation. 2017;101:1609-1615.
    Abstract    

    Abstract available

  56. GURGHEAN AL, Savulescu-Fiedler I, Mihailescu A
    Multiple cardiac complications after adjuvant therapy for breast cancer: the importance of echocardiography. A case report and review of the literature.
    Med Ultrason. 2017;19:117-120.
    Abstract    

    Abstract available

  57. HASHMI SK, Velasquez MP, Yee DL, Hui SK, et al
    Pediatric Acquired von Willebrand Syndrome in Cardiopulmonary Disorders: Do Laboratory Abnormalities Predict Bleeding Risk?
    J Pediatr Hematol Oncol. 2017;39:121-125.
    Abstract    

    Abstract available

  58. LI X, Liu Y, Zhang P
    Current aspects of pulmonary arterial hypertension and therapeutics.
    Minerva Cardioangiol. 2017;65:173-178.
    Abstract    

    Abstract available

  59. LEGROS L, Chabanne C, Camus C, Fournet M, et al
    Oral pulmonary vasoactive drugs achieve hemodynamic eligibility for liver transplantation in portopulmonary hypertension.
    Dig Liver Dis. 2017;49:301-307.
    Abstract    

    Abstract available

  60. KOULOVA A, Gass AL, Patibandla S, Gupta CA, et al
    Management of pulmonary hypertension from left heart disease in candidates for orthotopic heart transplantation.
    J Thorac Dis. 2017;9:2640-2649.
    Abstract    

    Abstract available

  61. ZHANG MZ, Qian DH, Xu JC, Yao W, et al
    Statins may be beneficial for patients with pulmonary hypertension secondary to lung diseases.
    J Thorac Dis. 2017;9:2437-2446.
    Abstract    

    Abstract available

  62. KOSANOVIC D, Herrera EA, Sydykov A, Orfanos SE, et al
    Pulmonary Hypertension due to Lung Diseases and/or Hypoxia: What Do We Actually Know?
    Can Respir J. 2017;2017:9598089.
    Abstract    



  63. PATTON DM, Enzevaie A, Day A, Sanfilippo A, et al
    A quality control exercise in the echo laboratory: Reduction in inter-observer variability in the interpretation of pulmonary hypertension.
    Echocardiography. 2017 Sep 19. doi: 10.1111/echo.13712.
    Abstract    

    Abstract available

  64. WU F, Yao W, Yang J, Zhang M, et al
    Protective effects of aloperin on monocroline-induced pulmonary hypertension via regulation of Rho A/Rho kinsase pathway in rats.
    Biomed Pharmacother. 2017;95:1161-1168.
    Abstract    

    Abstract available

  65. GIJTENBEEK M, Haak MC, Ten Harkel DJ, Te Pas AB, et al
    Persistent Pulmonary Hypertension of the Newborn in Twin-Twin Transfusion Syndrome: A Case-Control Study.
    Neonatology. 2017;112:402-408.
    Abstract    

    Abstract available

  66. SUZUKI S, Togari H, Potenziano JL, Schreiber MD, et al
    Efficacy of inhaled nitric oxide in neonates with hypoxic respiratory failure and pulmonary hypertension: the Japanese experience.
    J Perinat Med. 2017.
    Abstract    

    Abstract available

  67. ARORA TK, KumarArora A, Sachdeva MK, Rajput SK, et al
    Pulmonary Hypertension: Molecular Aspects of Current Therapeutic Intervention and Future Direction.
    J Cell Physiol. 2017 Sep 19. doi: 10.1002/jcp.26191.
    Abstract    

    Abstract available

  68. LAI MY, Chu SM, Lakshminrusimha S, Lin HC, et al
    Beyond the inhaled nitric oxide in persistent pulmonary hypertension of the newborn.
    Pediatr Neonatol. 2017 Aug 10. pii: S1875-9572(17)30480.
    Abstract    

    Abstract available

  69. GHOFRANI HA, Simonneau G, D'Armini AM, Fedullo P, et al
    Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study.
    Lancet Respir Med. 2017 Sep 8. pii: S2213-2600(17)30305.
    Abstract    

    Abstract available

  70. DEMEYERE M, Delacour D, Bouchart F, Michelin P, et al
    Persistent left superior vena cava: An unusual cause of curable pulmonary hypertension.
    Diagn Interv Imaging. 2017 Sep 14. pii: S2211-5684(17)30125.
    Abstract    



  71. KHARAT A, Hachulla AL, Noble S, Lador F, et al
    Modern diagnosis of chronic thromboembolic pulmonary hypertension.
    Thromb Res. 2017 Sep 9. pii: S0049-3848(17)30486.
    Abstract    

    Abstract available

  72. MAMMOTO T, Muyleart M, Konduri GG, Mammoto A, et al
    Twist1 in Hypoxia-induced Pulmonary Hypertension Through TGFbeta-Smad Signaling.
    Am J Respir Cell Mol Biol. 2017 Sep 15. doi: 10.1165/rcmb.2016-0323.
    Abstract    

    Abstract available

  73. CALHOUN BC
    Pulmonary hypertension: Clinical parameters of a difficult case in pregnancy.
    Linacre Q. 2017;84:243-247.
    Abstract    

    Abstract available

  74. NAEIJE R, Gerges M, Vachiery JL, Caravita S, et al
    Hemodynamic Phenotyping of Pulmonary Hypertension in Left Heart Failure.
    Circ Heart Fail. 2017;10.
    Abstract    

    Abstract available

  75. WRIGHT SP, Moayedi Y, Foroutan F, Agarwal S, et al
    Diastolic Pressure Difference to Classify Pulmonary Hypertension in the Assessment of Heart Transplant Candidates.
    Circ Heart Fail. 2017;10.
    Abstract    

    Abstract available

  76. GUAZZI M
    Exercise VE/VCO2 Slope: an Endurance Marker of Prognosis in Patients with HFpEF and Pulmonary Hypertension, at Least!
    J Card Fail. 2017 Sep 11. pii: S1071-9164(17)31168.
    Abstract    



  77. YUAN LB, Hua CY, Gao S, Yin YL, et al
    Astragalus Polysaccharides Attenuate Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats.
    Am J Chin Med. 2017;45:773-789.
    Abstract    

    Abstract available

  78. SUZUKI A, Kondoh Y
    The clinical impact of major comorbidities on idiopathic pulmonary fibrosis.
    Respir Investig. 2017;55:94-103.
    Abstract    

    Abstract available

  79. SHUDO Y, Ma M, Boyd JH, Woo YJ, et al
    Current status of domino heart transplantation.
    J Card Surg. 2017;32:229-232.
    Abstract    

    Abstract available

  80. MAITI A, Terracina KA, Das A, Chatterjee S, et al
    A tale of two hearts.
    Postgrad Med J. 2017;93:107.
    Abstract    



  81. AMSALLEM M, Boulate D, Aymami M, Guihaire J, et al
    Load Adaptability in Patients With Pulmonary Arterial Hypertension.
    Am J Cardiol. 2017 Jun 16. pii: S0002-9149(17)30953.
    Abstract    

    Abstract available

  82. GREEN DE, Murphy TC, Kang BY, Bedi B, et al
    Peroxisome proliferator-activated receptor-gamma enhances human pulmonary artery smooth muscle cell apoptosis through microRNA-21 and programmed cell death 4.
    Am J Physiol Lung Cell Mol Physiol. 2017;313:L371-L383.
    Abstract    

    Abstract available

  83. ORCHOLSKI ME, Khurshudyan A, Shamskhou EA, Yuan K, et al
    Reduced carboxylesterase 1 is associated with endothelial injury in methamphetamine-induced pulmonary arterial hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2017;313:L252-L266.
    Abstract    

    Abstract available

  84. DIEFFENBACH PB, Haeger CM, Coronata AMF, Choi KM, et al
    Arterial stiffness induces remodeling phenotypes in pulmonary artery smooth muscle cells via YAP/TAZ-mediated repression of cyclooxygenase-2.
    Am J Physiol Lung Cell Mol Physiol. 2017;313:L628-L647.
    Abstract    

    Abstract available

  85. ACKERMANN M, Gaumann A, Mentzer SJ, Hinrichs JB, et al
    Plexiform Vasculopathy in Chronic Thromboembolic Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2017 Sep 11. doi: 10.1164/rccm.201703-0591.
    Abstract    



  86. UMAR S, Cunningham CM, Itoh Y, Moazeni S, et al
    The Y Chromosome Plays a Protective Role in Experimental Hypoxic Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2017 Sep 21. doi: 10.1164/rccm.201707-1345.
    Abstract    



  87. WILKINS MR
    Apoptosis Signal-regulating Kinase 1 Inhibition in Pulmonary Hypertension: Too Much to ASK?
    Am J Respir Crit Care Med. 2017 Sep 20. doi: 10.1164/rccm.201709-1814.
    Abstract    



  88. COGHLAN JG, Galie N, Barbera JA, Frost AE, et al
    Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial.
    Ann Rheum Dis. 2017;76:1219-1227.
    Abstract    

    Abstract available

  89. KOWAL-BIELECKA O, Fransen J, Avouac J, Becker M, et al
    Update of EULAR recommendations for the treatment of systemic sclerosis.
    Ann Rheum Dis. 2017;76:1327-1339.
    Abstract    

    Abstract available

  90. HACHULLA E, Jais X, Cinquetti G, Clerson P, et al
    Pulmonary arterial hypertension associated with systemic lupus: results from the French Pulmonary Hypertension Registry.
    Chest. 2017 Aug 26. pii: S0012-3692(17)31430-7. doi: 10.1016/j.chest.2017.
    Abstract    

    Abstract available

  91. RAMJUG S, Hussain N, Hurdman J, Billings C, et al
    Idiopathic and Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: A Comparison of Demographic, Hemodynamic, and MRI Characteristics and Outcomes.
    Chest. 2017;152:92-102.
    Abstract    

    Abstract available

  92. BISCHOFF FC, Werner A, John D, Boeckel JN, et al
    Identification and Functional Characterization of Hypoxia-Induced Endoplasmic Reticulum Stress Regulating lncRNA (HypERlnc) in Pericytes.
    Circ Res. 2017;121:368-375.
    Abstract    

    Abstract available

  93. HWANGBO C, Lee HW, Kang H, Ju H, et al
    Modulation of Endothelial BMPR2 Activity by VEGFR3 in Pulmonary Arterial Hypertension.
    Circulation. 2017 Mar 29. pii: CIRCULATIONAHA.116.025390.
    Abstract    

    Abstract available

  94. LEISEGANG MS, Fork C, Josipovic I, Richter FM, et al
    Long Noncoding RNA MANTIS Facilitates Endothelial Angiogenic Function.
    Circulation. 2017;136:65-79.
    Abstract    

    Abstract available

  95. WEATHERALD J, Boucly A, Lau E, Godinas L, et al
    Are indexed values better for defining exercise pulmonary hypertension?
    Eur Respir J. 2017;50.
    Abstract    



  96. MULLIN CJ, Hsu S, Amancherla K, Wand A, et al
    Evaluation of criteria for exercise-induced pulmonary hypertension in patients with resting pulmonary hypertension.
    Eur Respir J. 2017;50.
    Abstract    



  97. KHATIB D, Boettcher BT, Freed JK, Pagel PS, et al
    Acute, Severe Pulmonary Arterial Hypertension During Off-Pump Coronary Artery Surgery: Is New Myocardial Ischemia, Cardiac Repositioning, or External Mitral Valve Compression the Culprit?
    J Cardiothorac Vasc Anesth. 2016 Mar 9. pii: S1053-0770(16)00138.
    Abstract    



  98. NARULA J, Kiran U, Malhotra Kapoor P, Choudhury M, et al
    Assessment of Changes in Hemodynamics and Intrathoracic Fluid Using Electrical Cardiometry During Autologous Blood Harvest.
    J Cardiothorac Vasc Anesth. 2017;31:84-89.
    Abstract    

    Abstract available

  99. CRONIN B, Robbins R, Maus T
    Pulmonary Artery Catheter Placement Using Transesophageal Echocardiography.
    J Cardiothorac Vasc Anesth. 2017;31:178-183.
    Abstract    

    Abstract available

  100. VITULO P, Beretta M, Martucci G, Hernandez Baravoglia CM, et al
    Challenge of Pregnancy in Patients With Pre-Capillary Pulmonary Hypertension: Veno-Arterial Extracorporeal Membrane Oxygenation as an Innovative Support for Delivery.
    J Cardiothorac Vasc Anesth. 2017 Apr 13. pii: S1053-0770(17)30401.
    Abstract    



  101. LI Y, Geng X, Wang H, Cheng G, et al
    CTRP9 ameliorates pulmonary-arterial hypertension through attenuating inflammation and improving endothelial cell survival and function.
    J Cardiovasc Pharmacol. 2016.
    Abstract    

    Abstract available

  102. KUNJUNJU AM, Gopagondanahalli KR, Chan Y, Sehgal A, et al
    Bronchopulmonary dysplasia-associated pulmonary hypertension: clues from placental pathology.
    J Perinatol. 2017 Sep 7. doi: 10.1038/jp.2017.
    Abstract    

    Abstract available

  103. LOOMIS Z, Eigenberger P, Redinius K, Lisk C, et al
    Hemoglobin induced cell trauma indirectly influences endothelial TLR9 activity resulting in pulmonary vascular smooth muscle cell activation.
    PLoS One. 2017;12:e0171219.
    Abstract    

    Abstract available

  104. POOR HD, Kawut SM, Liu CY, Smith BM, et al
    Pulmonary hyperinflation due to gas trapping and pulmonary artery size: The MESA COPD Study.
    PLoS One. 2017;12:e0176812.
    Abstract    

    Abstract available

  105. SOKUNBI OJ, Ekure EN, Temiye EO, Anyanwu R, et al
    Pulmonary hypertension among 5 to 18 year old children with sickle cell anaemia in Nigeria.
    PLoS One. 2017;12:e0184287.
    Abstract    

    Abstract available

  106. LAN CC, Peng CK, Tang SE, Huang KL, et al
    Carbonic anhydrase inhibitor attenuates ischemia-reperfusion induced acute lung injury.
    PLoS One. 2017;12:e0179822.
    Abstract    

    Abstract available

  107. FUCHS H, Rossmann N, Schmid MB, Hoenig M, et al
    Permissive hypercapnia for severe acute respiratory distress syndrome in immunocompromised children: A single center experience.
    PLoS One. 2017;12:e0179974.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;